How GLP-1 Medications Work: A Doctor Explains

If you've wondered why a once-weekly injection can quiet your appetite and change your relationship with food, this guide explains it. Knowing how GLP-1 medications work helps you use the medication well.

How GLP-1 medications work

GLP-1 stands for glucagon-like peptide-1, a hormone your own body already makes. Endogenous GLP-1 is produced in the intestines in response to food intake and is quickly inactivated by the enzyme dipeptidyl peptidase-4. Your gut releases a small burst of GLP-1 when you eat, and it fades within minutes.

GLP-1 medications are receptor agonists. They bind to the same receptors your natural hormone uses, but they're engineered to last far longer, so many are dosed once a week. By activating the GLP-1 receptor, these agents enhance glucose-dependent insulin secretion, inhibit glucagon release, and slow gastric emptying.

They also suppress appetite and enhance satiety by acting on the central nervous system, which reduces calorie intake and leads to weight loss.

The medication is not a stimulant and does not "melt fat." It amplifies a normal satiety signal your body uses every day.

The gut-brain connection

Most people notice the effect in the brain first. GLP-1 receptor agonists activate the GLP-1 receptors in the hypothalamus, the brain region that regulates food intake. This decreases the feeling of hunger and causes the patient to eat less.

There's also a reward component, and many patients describe "food noise" going quiet. In a placebo-controlled imaging study, a GLP-1 receptor agonist decreased food intake and food-related brain responses in the insula, amygdala, putamen, and orbitofrontal cortex (areas tied to craving and reward, not just raw hunger).

What's happening in your stomach

The second mechanism is digestive. GLP-1 receptor agonists slow gastric emptying within the first hour of eating, which produces the feeling of being full. Food stays in your stomach longer, so you feel satisfied sooner and the fullness lasts.

This slowing is mediated partly through the vagus nerve, the main communication line between your gut and brainstem. GLP-1 receptors are present in the pancreas and also in the central and peripheral nervous systems, including the enteric nervous system of the gastrointestinal tract. Activating these receptors may influence nerve signals that control gastric motility.

The same slowing explains the most common early side effects. Nausea or early fullness is usually most noticeable right after a dose increase. Our medications resources include a guide to managing those symptoms.

Blood sugar, insulin, and metabolism

GLP-1 was first studied as a diabetes hormone. It helps maintain glucose homeostasis by enhancing insulin secretion, suppressing glucagon release, delaying gastric emptying, and acting on the central nervous system to regulate satiation and satiety.

The insulin effect is glucose-dependent. It increases when blood sugar is high and eases off when it's normal, so these medications carry a low risk of hypoglycemia when used on their own. GLP-1 receptor agonists also reduce triglycerides and low-density lipoprotein cholesterol, reduce adipose tissue inflammation, and minimize ectopic fat deposition.

Semaglutide vs. tirzepatide: one target or two?

Semaglutide is a GLP-1 receptor agonist. Tirzepatide adds a second target: GIP (glucose-dependent insulinotropic polypeptide), another gut hormone. Research shows that dual GIP and GLP-1 receptor agonism more potently inhibited the hunger-promoting AgRP neurons and suppressed food intake than either agonist alone.

Some people respond differently to each medication. Neither is universally better. It depends on your physiology, your goals, and how you tolerate each one. Dr. Tran Le, MD, DABOM, leads our practice and matches the medication to the person.

She is triple board-certified in Obesity Medicine, Addiction Medicine, and Occupational and Environmental Medicine. Compare options on our semaglutide and tirzepatide pages.

The medication is one part of the plan

GLP-1s work with your body's signals, so lifestyle still matters. The medication makes it much easier to eat less, and protein, strength work, hydration, and sleep protect your muscle and metabolism while the weight comes off. Patients who use the medication as a tool alongside those habits tend to feel best and hold their results longer.

Compounded medications are not FDA-approved. This article is educational, not medical advice for your specific situation. Talk with a clinician who knows your history.

Frequently asked questions

Does a GLP-1 speed up my metabolism?

No, not like a stimulant. Most of the weight effect comes from reduced appetite, slower gastric emptying, and improved satiety signaling. GLP-1 receptor agonists also enhance leptin signaling by reducing leptin resistance, which increases the effectiveness of leptin in suppressing appetite.

How fast does a GLP-1 start working?

Many people feel reduced appetite within the first week or two, because the gastric-emptying and brain effects begin quickly. Visible weight change is more gradual. Doses increase slowly to limit side effects. See how it works for what to expect.

Is compounded semaglutide the same as the brand-name product?

No. Compounded medications are prepared by a licensed pharmacy and are not FDA-approved, and they are not the same as any brand-name drug. We also prescribe brand-name GLP-1s such as Wegovy, Ozempic, Zepbound, and Mounjaro through our à la carte plan. See pricing for details.

Next steps

The next step is a clinical evaluation. We care for patients across Texas and Utah entirely online, with a plan built around your health history and goals. Start your consultation and we'll talk through your options.

How GLP-1 Medications Work: A Doctor Explains